MAKING A DEAL: Dexa Medica Group, a leading Indonesian

MAKING A DEAL: Dexa Medica Group, a leading Indonesian
pharmaceutical company, signed on July 1 a cooperation agreement
with DR. Reddy's Laboratories, based in India, for marketing
oncology and biotechnology products. PT Ferron Par
Pharmaceuticals, a member of Dexa Medica Group, will register
several DR. Reddy's oncology products with the Food and Drug
Monitoring Agency and market the products via distributor Anugrah
Argon Medica. PT Dexa Medica will market biotechnology products
in several therapeutic categories. Pictured above (left to right)
are: Ferry Soetikno, Managing Director of PT Dexa Medica; Satish
Reddy, Managing Director and COO of DR. Reddy's Laboratories; and
Djoko Sujono, Managing Director of PT Ferron Par Pharmaceuticals.